Factors associated with presence of ascending aortic atherosclerosis in CABG patients
Thomas Schachner1, Georg Nagele, Andre Kacani
1Department of Cardiac Surgery, Innsbruck University Hospital, Innsbruck, Austria.
Insights
Epiaortic scanning during coronary artery bypass grafting (CABG) can identify patients with ascending aortic arteriosclerosis. Key predictors include age, hypertension, cerebrovascular disease, and peripheral vascular disease.
Area of Science:
- Cardiovascular Surgery
- Vascular Medicine
- Diagnostic Imaging
Background:
- The routine use of epiaortic scanning during coronary artery bypass grafting (CABG) remains debated.
- Determining selective criteria for this imaging modality is crucial for patient care.
Purpose of the Study:
- To identify patient-specific factors that predict atherosclerotic ascending aortic wall thickening.
- To inform the selective application of epiaortic scanning in CABG patients.
Main Methods:
- Epiaortic scanning was performed on 500 patients undergoing CABG.
- Ascending aortic wall thickness was measured and correlated with clinical and demographic variables.
Main Results:
- Ascending aortic wall thickness correlated with age, creatinine, EuroSCORE, and descending aortic thickness.
- Hypertension, unstable angina, COPD, cerebrovascular disease, and peripheral vascular disease were associated with increased wall thickness.
- Multivariate analysis identified descending aortic thickness, cerebrovascular disease, and peripheral vascular disease as independent predictors.
Conclusions:
- Epiaortic scanning is not routinely indicated but should be considered for specific patient groups.
- Patients with older age, hypertension, unstable angina, COPD, cerebrovascular disease, peripheral vascular disease, elevated creatinine, higher EuroSCOREs, or thickened descending aorta are candidates.
Background:
The indication for epiaortic scanning during coronary artery operation is still a matter of debate. Whether this test should be carried out selectively or on a routine basis is unclear. The aim of this study was to determine factors that predict the presence of atherosclerotic ascending aortic wall thickening in patients undergoing coronary artery bypass grafting (CABG).
Methods:
A total of 500 CABG patients underwent epiaortic scanning using a high-frequency linear ultrasonic probe. Maximum ascending aortic wall thickness was measured and correlated with patient-related variables.
Results:
Maximum ascending aortic wall thickness significantly correlated with age (p < 0.001), preoperative creatinine level (p = 0.004), European system for cardiac operative risk evaluation (EuroSCORE, p < 0.001), and maximum descending aortic wall thickness (p < 0.001). Body mass index and left ventricular ejection fraction showed no correlation with maximum ascending aortic wall thickness. Of the categorical variables, hypertension (p = 0.02), unstable angina (p = 0.04), chronic obstructive pulmonary disease (p = 0.02), cerebrovascular disease (p < 0.001), and peripheral vascular disease (p < 0.001) were associated with increased ascending aortic wall thickness whereas sex, diabetes, acute cases, and previous cardiac operation were not. Multivariate analysis revealed maximum descending aortic wall thickness (p < 0.001), cerebrovascular disease (p = 0.03), and peripheral vascular disease (p = 0.04) as independent variables significantly associated with maximum ascending aortic wall thickness.
Conclusions:
If epiaortic scanning is not carried out routinely for detection of ascending aortic arteriosclerosis it should at least be performed in patients with old age, hypertension, unstable angina, chronic obstructive pulmonary disease, cerebrovascular disease, peripheral vascular disease, elevated creatinine levels, higher EuroSCOREs, and increased wall thickness of the descending aorta.
Related Concept Videos
Coronary Artery Disease I: Introduction
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Aortic Regurgitation I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Aortic Regurgitation III: Medical Management

